In Memoriam

In memoriam: John Hoover Hash

ASBMB Today Staff
Dec. 18, 2023

John Hoover Hash, who served for more than three decades on the Vanderbilt University Medical Center faculty and had been a member of the American Society for Biochemistry and Molecular Biology since 1965, died June 20 in Nashville. He was 94.

John Hoover Hash

Born Feb. 23, 1929, in Franklin County, Va., the 11th of 12 children, Hash graduated as his high school valedictorian when he was 16. After earning a BS at Roanoke College and then teaching high school for two years, he was drafted into the Army. During the Korean War, he was stationed at Fort Detrick, Md., where biological weapons were being developed —a program he opposed.

Hash earned a Ph.D. in biochemistry from Virginia Tech in 1957 and held a postdoctoral fellowship at Columbia University. He worked at Lederle Labs in New York for six years before Vanderbilt hired him as an assistant professor in 1964.

At Lederle, Hash had discovered an unusual bacteriolytic enzyme produced by the fungus Chalaropsis. At Vanderbilt, he crystalized and and characterized the enzyme as a lysozyme that can kill bacteria by breaking through their tough membranes. He capped his research on antibiotics by editing a volume for the Methods in Enzymology series.

After Hash was appointed associate dean of biomedical science and director of sponsored research at Vanderbilt in 1976, he began helping colleagues secure research funding. He helped write computer programs to extract data from grant records and the VUMC Reporter dubbed him the “godfather of grants” when he retired as emeritus professor of microbiology and immunology in 1994.

Hash was elected a fellow of the American Association for the Advancement of Science in 1966. He was a member of the National Advisory Research Resources Council of the National Institutes of Health from 1991 to 1995.

In retirement, Hash focused on woodworking, pastel and oil painting, reading and travel. His art was eclectic; he painted whatever he liked, for the fun of it. He and his wife traveled to every continent except Antarctica.

He was preceded in death by his wife of more than 62 years, Mary Ann Hash. He survived by three children and their spouses, six grandchildren and two great-grandchildren.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Redefining excellence to drive equity and innovation
Award

Redefining excellence to drive equity and innovation

Jan. 22, 2026

Donita Brady will receive the ASBMB Ruth Kirschstein Award for Maximizing Access in Science at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

ASBMB names 2026 fellows
Announcement

ASBMB names 2026 fellows

Jan. 19, 2026

The American Society for Biochemistry and Molecular Biology announced that it has named 16 members as 2026 fellows of the society.

ASBMB members receive ASM awards
Member News

ASBMB members receive ASM awards

Jan. 19, 2026

Jennifer Doudna, Michael Ibba and Kim Orth were recognized by the American Society for Microbiology for their achievements in leadership, education and research.

Mining microbes for rare earth solutions
Award

Mining microbes for rare earth solutions

Jan. 14, 2026

Joseph Cotruvo, Jr., will receive the ASBMB Mildred Cohn Young Investigator Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

McKnight wins Lasker Award
Member News

McKnight wins Lasker Award

Jan. 12, 2026

He was honored at a gala in September and received a $250,000 honorarium.

Building a stronger future for research funding
Interview

Building a stronger future for research funding

Jan. 9, 2026

Hear from Eric Gascho of the Coalition for Health Funding about federal public health investments, the value of collaboration and how scientists can help shape the future of research funding.